ArticleOncology letters2023

Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma.

Jiawei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.